These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26178446)

  • 1. Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice.
    Sun L; Dai Y; Wang C; Chu Y; Su X; Yang J; Zhou J; Huang W; Qian H
    Chem Biol Drug Des; 2015 Dec; 86(6):1482-90. PubMed ID: 26178446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumaglutide, a novel long-acting GLP-1 analog, inhibits β-cell apoptosis in vitro and invokes sustained glycemic control in vivo.
    Sun L; Wang C; Dai Y; Chu Y; Han J; Zhou J; Cai X; Huang W; Qian H
    Eur J Pharmacol; 2015 Nov; 767():211-9. PubMed ID: 26481165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
    Badole SL; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Jangam GB; Ghule AE; Raut CG; Khedkar VM; Coutinho EC
    Chem Biol Interact; 2013 Apr; 203(2):530-41. PubMed ID: 23466488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism.
    Gao H; Song Z; Zhao Q; Wu Y; Tang S; Alahdal M; Shen Y; Xing Y; Pan Y; Li J; Zhang Y; Jin L
    Cell Physiol Biochem; 2018; 48(3):1112-1122. PubMed ID: 30041175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
    Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
    Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
    Badole SL; Mahamuni SP; Bagul PP; Khose RD; Joshi AC; Ghule AE; Bodhankar SL; Raut CG; Khedkar VM; Coutinho EC; Wagh NK
    Eur J Pharmacol; 2013 Jan; 698(1-3):470-9. PubMed ID: 23117087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1.
    Lin LC; Lee LC; Huang C; Chen CT; Song JS; Shiao YJ; Liu HK
    Phytomedicine; 2019 Sep; 62():152946. PubMed ID: 31102890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
    Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
    Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
    Akarte AS; Srinivasan BP; Gandhi S
    Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Glucagon-Like Peptide-1-albumin Recombinant Protein with Prolonged Hypoglycemic Effect Provides Efficient and Beneficial Control of Glucose Metabolism in Diabetic Mice.
    Li C; Yang M; Hou G; Liu S; Huan Y; Yu D; Sun S; Liu Q; Yan S; Shen Z
    Biol Pharm Bull; 2017 Sep; 40(9):1399-1408. PubMed ID: 28626167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nonapeptide GLP (28-36) amide derivatives with improved hypoglycemic and body weight lowering effects.
    Li L; Wu L; E X; Yan W; Cai X; Han J; Sun L
    Bioorg Med Chem; 2019 Apr; 27(8):1670-1676. PubMed ID: 30878191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.
    Perry RA; Craig SL; Gault VA; Flatt PR; Irwin N
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34370015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
    Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavone Hispidulin Stimulates Glucagon-Like Peptide-1 Secretion and Ameliorates Hyperglycemia in Streptozotocin-Induced Diabetic Mice.
    Wang Y; Wang A; Alkhalidy H; Luo J; Moomaw E; Neilson AP; Liu D
    Mol Nutr Food Res; 2020 Mar; 64(6):e1900978. PubMed ID: 31967385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the anti-diabetic activity of GLP-1 by fusion with globular adiponectin.
    Gao M; Tong Y; Li W; Gao X; Yao W
    Artif Cells Nanomed Biotechnol; 2013 Jun; 41(3):159-64. PubMed ID: 22889326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific fatty chain-modified exenatide analogs with balanced glucoregulatory activity and prolonged in vivo activity.
    Sun L; Huang X; Han J; Cai X; Dai Y; Chu Y; Wang C; Huang W; Qian H
    Biochem Pharmacol; 2016 Jun; 110-111():80-91. PubMed ID: 27155328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.
    Manaer T; Yu L; Zhang Y; Xiao XJ; Nabi XH
    J Ethnopharmacol; 2015 Jul; 169():269-74. PubMed ID: 25922265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.